Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
CI ›
CINCOR
Trademark search for:
CINCOR
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-07-02 — Application filed
2021-07-06 — Application filed
2021-09-13 — Application filed
2022-03-23 — Assigned to examiner
2022-03-29 — Examiners amendment -written
2022-03-29 — Approved for pub - principal register
2022-03-29 — Examiners amendment e-mailed
2022-03-29 — Notification of examiners amendment e-mailed
2022-03-29 — Examiner's amendment entered
2022-04-13 — Notification of notice of publication e-mailed
2022-05-03 — Published for opposition
2022-05-03 — Official gazette publication confirmation e-mailed
2022-06-28 — Noa e-mailed - sou required from applicant
2022-11-01 — Attorney/dom.rep.revoked and/or appointed
2022-11-01 — Teas change of correspondence received
2022-11-01 — Teas revoke/app/change addr of atty/dom rep received
2022-11-01 — Teas withdrawal of attorney received-firm retains
2022-11-02 — Sou teas extension received
2022-11-02 — Sou extension 1 filed
2022-11-02 — Sou extension 1 granted
2022-11-04 — Notice of approval of extension request e-mailed
2023-07-31 — Application abandoned
2023-07-31 — Application abandoned
2023-07-31 — Final status recorded
Owner Information
Cincor Pharma, Inc.
Cincinnati , OH
Cincor Pharma, Inc.
Cincinnati , OH
Correspondent
Kevin M. Bovard BAKERHOSTETLER 1735 Market Street, Suite 3300 Philadelphia, PA 19103-7501 UNITED STATES
Filing Details
Filing Date:
2021-07-02
Status Date:
2023-07-31
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.